Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on CO2 utilization. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN112898205A details a green benzimidazole synthesis using CO2 and a mesoporous polymer catalyst, offering cost reduction in pharmaceutical intermediate manufacturing.
Novel patent CN116239529B enables atmospheric CO2 utilization for alkaloid synthesis, offering significant cost reduction and supply chain reliability for pharmaceutical intermediate manufacturing.
Patent CN114560827A reveals a metal-free route to 1H-benzothiazoles using stable o-aminodisulfides and CO2, offering significant cost reduction and supply chain reliability for pharmaceutical intermediates.
Patent CN111303073A details a green route for Fenthiolamide using benzothiazolone, offering cost reduction and high purity for herbicide manufacturing.
Solve high-cost catalysts & harsh conditions in benzothiazole synthesis. New CO2-based method achieves 85.9% yield at 80°C. Contact for CDMO solutions.